Iv%2525252520dexamethasone

# IV Dexamethasone ## Overview Dexamethasone is a high-potency, long-acting synthetic glucocorticoid with minimal mineralocorticoid activity. It provides potent anti-inflammatory and immunosuppressive effects. ## Primary Indications * Cerebral edema (associated with brain tumors, neurosurgery, or trauma) * Refractory status asthmaticus * Severe COVID-19 (requiring oxygen therapy) * Bacterial meningitis (adjunctive therapy) * Anti-emetic prophylaxis (chemotherapy-induced) * Severe allergic reactions/anaphylaxis ## Adult Dosing * **Cerebral Edema:** Initial 10 mg IV, followed by 4 mg IV every 6 hours. * **COVID-19:** 6 mg IV once daily for up to 10 days. * **Bacterial Meningitis:** 10 mg IV every 6 hours for 4 days (ideally given 15-20 minutes prior to first antibiotic dose). * **Chemotherapy-Induced Nausea/Vomiting:** 10–20 mg IV as a single dose prior to chemotherapy. * **Status Asthmaticus:** 8–12 mg IV once; may repeat every 6–12 hours based on clinical response. ## Pediatric Dosing * **Cerebral Edema:** Loading dose 1–2 mg/kg IV; maintenance 1–1.5 mg/kg/day divided every 4–6 hours (max dose depends on indication/protocol). * **Bacterial Meningitis:** 0.15 mg/kg IV every 6 hours for 4 days (start prior to/with 1st antibiotic dose). * **Status Asthmaticus:** 0.3–0.6 mg/kg IV once (max 10–20 mg per facility protocol). * **Anti-emetic:** 0.25–0.5 mg/kg IV (max 10–20 mg). ## Dose Adjustments * **Hepatic Impairment:** Clearance may be decreased; monitor closely for enhanced corticosteroid effects. * **Renal Impairment:** No standard dosage adjustment required. * **Chronic Corticosteroid Use:** Tapering is required to prevent adrenal insufficiency; dosing must be individualized. ## Contraindications * Systemic fungal infections. * Hypersensitivity to dexamethasone or any component of the formulation. * Administration of live or attenuated vaccines while on immunosuppressive doses. ## Adverse Effects * **Common:** Hyperglycemia, hypertension, insomnia, mood changes, increased appetite. * **Serious:** Adrenal suppression, gastrointestinal ulceration/perforation, delayed wound healing, immunosuppression/increased infection risk, psychiatric disturbances, osteoporosis (long-term). ## Key Drug Interactions * **CYP3A4 Inducers (e.g., Phenytoin, Phenobarbital, Rifampin):** Decreased dexamethasone efficacy. * **CYP3A4 Inhibitors (e.g., Ketoconazole, Ritonavir):** Increased dexamethasone toxicity risk. * **NSAIDs:** Increased risk of gastrointestinal ulceration. * **Diuretics:** Increased risk of hypokalemia. * **Warfarin:** Anticoagulant effect may be increased or decreased; monitor INR closely. ## Monitoring * Serum glucose (especially in patients with diabetes). * Blood pressure. * Electrolytes (potassium, sodium). * Signs/symptoms of infection. * Psychiatric status (mood/behavioral changes). ## Clinical Pearls * **Potency:** 0.75 mg of dexamethasone is equivalent to approximately 5 mg of prednisone. * **Long-Acting:** Dexamethasone has a biological half-life of 36–54 hours, making it less suitable for alternate-day therapy but preferred when a long duration of action is needed. * **COVID-19 timing:** Clinical efficacy in COVID-19 is established specifically for patients requiring supplemental oxygen or invasive mechanical ventilation; it may be harmful in mild cases (pre-oxygen requirement). * **Note:** Always verify specific dosing protocols (e.g., local institutional guidelines for oncology or pediatrics) as they often vary based on local clinical pathways. *** **Educational Disclaimer:** This information is for educational purposes only and does not constitute medical advice. Prescribing decisions must be based on clinical judgment and verified against current institutional protocols, official package inserts, and evidence-based clinical databases (e.g., Lexicomp, UpToDate).